£141.33

Primary Central Nervous System Lymphoma (PCNSL): Incidence, Management & Outcomes (Neurology - Laboratory and Clinical Research Developments)

Price data last checked 50 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£141 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 41 days · 41 data points (no recent data)

Historical
Generating forecast…
£142.45 £141.22 £141.49 £141.76 £142.02 £142.29 £142.56 10 June 2026 20 June 2026 30 June 2026 10 July 2026 20 July 2026

Price Distribution

Price distribution over 41 days • 2 price levels

Days at Price
Current Price
1 day · current 40 days 0 10 20 30 40 £141 £142 Days at Price

Price Analysis

Most common price: £142 (40 days, 97.6%)

Price range: £141 - £142

Price levels: 2 different prices over 41 days

Description

Primary central nervous system lymphoma (PCNSL) is an extranodal form of non-Hodgkins lymphoma (NHL) occurring in the craniospinal axis that accounts for 13% of all central nervous system malignancies. The majority of PCNSLs are high-grade B-cell lymphomas that differ from systemic B-cell NHLs in their less favorable prognosis. PCNSL appears to be increasing in incidence, reaching its peak in the fifth to seventh decades of life in immunocompetent patients. This book aims to provide up-to-date knowledge on the biology, diagnosis and treatment strategies associated with PCNSL. Separate chapters are specifically devoted to the biology, pathology, diagnosis, radiation therapy, chemotherapy regimens, emerging new agents, specific subtypes, and outcome associated with PCNSL. The authors are scientists and practicing physicians at university hospitals in Japan and South Korea. The book is written for postgraduate students, residents, basic scientists and physicians, as well as all medical professionals. The material covered in this book will serve as a foundation for the readers to keep up with current and future developments in this specific field of research and clinical practice.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
01 September 2016
Listed Since
22 April 2016

Barcode

No barcode data available

Similar Products You Might Like

Springer Tumors of the Central Nervous System, Volume 9
96% match

Springer Tumors of the Central Nervous System, Volume 9

Springer

£114.89 18 Jul 2026
Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy
96% match

Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy

Springer

£114.12 11 Jul 2026
Rare Lymphomas (Hematologic Malignancies)
96% match

Rare Lymphomas (Hematologic Malignancies)

Springer

£99.53 12 Aug 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
96% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.39 15 Jul 2026
Springer - Lymphoma and Leukemia of the Nervous System Book
96% match

Springer - Lymphoma and Leukemia of the Nervous System Book

Springer

£108.01 06 Aug 2026
Lymphoma and Leukemia of the Nervous System
96% match

Lymphoma and Leukemia of the Nervous System

Springer

£107.85 06 Jul 2026
Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
96% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£141.67 19 Aug 2026
Adult CNS Radiation Oncology: Principles and Practice
96% match

Adult CNS Radiation Oncology: Principles and Practice

Springer

£136.50 15 Aug 2026
Neuro-Oncology for the Clinical Neurologist
96% match

Neuro-Oncology for the Clinical Neurologist

Elsevier

£78.29 22 Aug 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£144.43 20 Aug 2026
Aggressive Lymphomas (Hematologic Malignancies)
96% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£89.37 09 Jul 2026
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
96% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£91.75 17 Jul 2026
Tumors of the Pediatric Central Nervous System
96% match

Tumors of the Pediatric Central Nervous System

Thieme

£196.63 13 Jul 2026
Central Nervous System Leukemia: Prevention and Treatment: 13 (Developments in Oncology, 13)
96% match

Central Nervous System Leukemia: Prevention and Treatment: 13 (Developments in Oncology, 13)

Springer

£38.61 15 Jul 2026
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
96% match

Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

Springer

£142.76 12 Aug 2026
The International Consensus Classification of Myeloid and Lymphoid Neoplasms
96% match

The International Consensus Classification of Myeloid and Lymphoid Neoplasms

Lippincott Williams & Wilkins

£117.11 02 Jul 2026
Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
96% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£155.47 12 Jul 2026
Elsevier Neuro-Oncology Part I: Volume 104 Handbook
96% match

Elsevier Neuro-Oncology Part I: Volume 104 Handbook

Elsevier

£143.48 18 Jul 2026
Diagnosis and Management of Malignant Solid Tumors in Infants and Children: 37 (Developments in Oncology, 37)
96% match

Diagnosis and Management of Malignant Solid Tumors in Infants and Children: 37 (Developments in Oncology, 37)

Springer

£108.75 13 Jul 2026
MEDULLOBLASTOMA BOOK (Neuroscience Research Progress)
96% match

MEDULLOBLASTOMA BOOK (Neuroscience Research Progress)

£166.00 10 Jul 2026
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)
96% match

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research)

Springer

£121.98 13 Aug 2026
Atlas of Cerebrospinal Fluid Cells
96% match

Atlas of Cerebrospinal Fluid Cells

Springer

£77.86 07 Jul 2026
Springer Malignant Lymphomas and Hodgkin's Disease Volume 66
96% match

Springer Malignant Lymphomas and Hodgkin's Disease Volume 66

Springer

£121.01 03 Aug 2026
Springer - Oncology of CNS Tumors Medical Reference Book
96% match

Springer - Oncology of CNS Tumors Medical Reference Book

Springer

£141.76 20 Jul 2026